Figure 1 | Scientific Reports

Figure 1

From: Reduced-toxicity myeloablative conditioning consisting of 8-Gy total body irradiation, cyclophosphamide and fludarabine for pediatric hematological malignancies

Figure 1

Kaplan-Meier estimates of overall survival (OS) and relapse-free survival (RFS) of patients who received allo-HSCT after an 8-Gy TBI/FLU/CY conditioning regimen.

(a) 5-year OS and RFS for all 31 patients, (b) 5-year OS and RFS for 11 patients with acute lymphoblastic leukemia, (c) 5-year OS and RFS for 18 patients with myeloid malignancies (acute myeloid leukemia, myelodysplastic syndrome or juvenile myelomonocytic leukemia patients).

Back to article page